Good news: Zhejiang Puli Pharmaceutical has been selected as one of the fourth batch of innovative s

Good news: Zhejiang Puli Pharmaceutical has been selected as one of the fourth batch of innovative small and medium-sized enterprises in Hangzhou for two thousand twenty-four! Zhejiang Puli Pharmaceutical has been selected as one of the fourth batch of innovative small and medium-sized enterprises in Hangzhou for two thousand twenty-four! Recently, the Hangzhou Municipal Bureau of Economy and Information Technology announced the list of the fourth batch of innovative small and medium-sized enterprises in Hangzhou for two thousand twenty-four, with twenty-four enterprises from the development zone on the list. Zhejiang Puli Pharmaceutical Co., Ltd. was awarded the title of the fourth batch of innovative small and medium-sized enterprises in Hangzhou for two thousand twenty-four! Innovative small and medium-sized enterprises generally refer to small and medium-sized enterprises with relatively sound innovation mechanisms, with technological innovation as the core, forming comprehensive and sustainable innovation capabilities in technology, brand, system, management, culture, etc. Innovative small and medium-sized enterprises have a high level of specialization, strong innovation capabilities, and development potential, which are the fundamental strength of high-quality small and medium-sized enterprises. The cultivation and recognition of provincial-level specialized, refined, unique, and new small and medium-sized enterprises should be selected and recommended from innovative enterprises. In other words, innovative small and medium-sized enterprises are the first step for enterprises to embark on the path of specialized, refined, unique, and new development. National high-tech enterprises within the validity period can be directly recognized as innovative small and medium-sized enterprises. Only by becoming an innovative small and medium-sized enterprise can one apply for provincial-level specialized, refined, special and new small and medium-sized enterprises and national specialized, refined, special and new "little giant" enterprises. Strong innovation capability and good quality and efficiency are the new engines for industrial development and the hard support for the real economy. Being listed on the honor list of Zhejiang Puli Pharmaceutical is not only a recognition of Puli Pharmaceutical's innovation ability, professional level, and development potential, but also an important step for Zhejiang Puli to embark on the path of specialized, refined, and innovative development! About Zhejiang Puli Pharmaceutical Co., Ltd. Zhejiang Puli Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Hainan Puli Pharmaceutical Co., Ltd. Zhejiang Puli Pharmaceutical has an excellent organizational system and capability for formulation development, industrial transformation, and production manufacturing in China. It has a scientific and comprehensive quality management system and has successfully passed GMP certifications in China, the European Union, and the United States multiple times. Zhejiang Puli Pharmaceutical has formed a complete international manufacturing and quality control system, and has an excellent team with efficient research and development and international registration. Zhejiang Puli Pharmaceutical is willing to provide comprehensive customized services for CDMOCMO partners who are interested in entering the international market. We welcome domestic and international friends and customers to negotiate CDMOCMO business and achieve win-win development. (ST Puli)